contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


qlife-holding-one-pager-continues-to-show-low-market-implied-probability-of-success-pos-for-egoo-health

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Equity Research Analyst

Henrik Ekman

Philip Coombes

CEO, Sweden

Claus Thestrup

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.

Qlife Holding

Qlife Holding – Even after huge share price increases, our updated One-pager continues to show low market implied Probability of Success (PoS) for Egoo Health
 
Qlife Holding’s announced on Monday December 4th that they have entered a collaboration agreement with Chinese based Hipro Biotechnology who will distribute and sell Egoo Health systems developed by Qlife Holding in China.

Even after huge share price increases, our updated One-pager continues to show low market implied Probability of Success (PoS) for Egoo Health
&nbsp;Qlife Holding&rsquo;s announced on Monday December 4th that they have entered a collaboration agreement with Chinese based Hipro Biotechnology who will distribute and sell Egoo Health systems developed by Qlife Holding in China. Although potentially very positive for Qlife Holding from a commercialization and financial perspective and even after share price increases of approximately 40 percent since the announcement, our updated model suggest that the market implicitly does not fully discounts the potential upside from the Hipro Biotechnology deal. Actually, the model indicates a lower implied likelihood of Qlife Holding to successfully launch Egoo Health compared to our model update in the August 2023.
One explanation could be that Qlife Holding is also considering engaging into partnership arrangements in other regions. Although partnerships can potentially be supportive of a faster and less financial burdensome commercial roll-out of Egoo Health, some investors perhaps assess that it will be less valuable to share the potential with partners rather than Qlife Holding trying to capture the opportunities themselves. This way, the market do actually appreciate the Hipro Biotechnology deal, but they attribute less value to the remaining part of Qlife Holdings potential in other regions following the increased emphasis on engaging into partnerships.
An additional explanation could be that the market assesses there is an increased likelihood that Qlife Holding will need to raise capital that could potentially dilute shareholders. This is a permanent risk factor to consider for investors in life-science and biotech companies who are in their developing and cash burning phase, but the level of this type of risk can off course increase when companies approach their guided timeline for expected funding requirements.
Disclaimer: HC Andersen Capital receives payment from Qlife Holding for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup&nbsp;08:40 AM 07-12-2023.

HC Andersen Capital

Qlife Holding (One-pager): Continues to show low market implied Probability of Success (PoS) for Egoo Health

Qlife Holding

Stay up to date with our newsletter